Intravascular Catheters Market: Market Size & Forecast 2026

Intravascular catheters are sterile medical devices inserted into veins or arteries to facilitate fluid administration, drug delivery, blood sampling, and hemodynamic monitoring in clinical settings. The global market is estimated at $8.61 billion in 2025 and is projected to expand at a compound annual growth rate of about 12.05%, reaching the mid-teens in billions by the early 2030s. Demand spans central venous, peripheral intravenous, peripherally inserted central, and specialty catheters used across hospitals, ambulatory surgical centers, and home-infusion services.

• •Estimated global market size of $8.61 billion in 2025 with projected 12.05% annual growth
• •Product scope includes central venous, peripheral IV, PICC, and specialty catheters
• •Primary end users are hospitals, outpatient facilities, and home healthcare providers

Rising global incidence of cardiovascular disease, cancer, diabetes, and chronic kidney disease is increasing the number of patients requiring long-term vascular access for treatment and monitoring. Aging populations in North America, Europe, and parts of Asia are expanding the procedural volume of catheter placements, while growing surgical caseloads and intensive care utilization sustain baseline hospital demand. The shift of infusion therapy into outpatient and home-care settings is also opening new avenues for product adoption beyond the traditional hospital channel.

• •Growing burden of chronic and lifestyle-related diseases requiring vascular access
• •Aging demographics driving higher procedural volumes in developed and emerging markets
• •Migration of infusion therapy into home and ambulatory care expanding the addressable market

The market is typically segmented by product type, application, end user, and geography, with central venous and peripherally inserted central catheters representing major revenue categories alongside peripheral intravenous devices. By region, North America leads in revenue due to high procedure volumes, advanced reimbursement structures, and early adoption of premium safety products, while Asia-Pacific is the fastest-growing region on the back of expanding hospital infrastructure in China and India. Europe represents a mature but steadily growing segment shaped by universal healthcare systems and an emphasis on infection-prevention standards.

• •Central venous and PICC catheters generate a significant share of category revenue
• •North America leads current revenue, with Asia-Pacific posting the highest growth rates
• •Hospitals remain the dominant end-user segment, though outpatient and home infusion are gaining share

What are the recent trends and outlook?

The most prominent trends shaping the category are the development of antimicrobial and antithrombogenic catheter coatings, broader adoption of ultrasound-guided insertion, and the integration of catheters with digital monitoring platforms that track pressure and flow in real time. Manufacturers are also investing in materials science to improve biocompatibility and reduce dwell-time complications. Looking ahead, demand for minimally invasive vascular access in outpatient oncology, dialysis, and home infusion is expected to remain the primary engine of growth through the next decade.

• •Antimicrobial coatings and ultrasound-guided placement are becoming standard in clinical protocols
• •Digital and connected catheter systems are emerging to support remote monitoring
• •Outpatient oncology, dialysis, and home-infusion applications are expected to drive the next wave of demand